Parkinson Disease - Psychology
Research News and Information

Saturday, November 21, 2009

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.

Nov 2009 OBJECTIVE: To investigate the incidence of and risk factors for cognitive impairment in a large, well-defined clinical trial cohort of patients with early Parkinson disease (PD). METHODS: The Mini-Mental State Examination (MMSE) was administered ... Read more...

Driving under low-contrast visibility conditions in Parkinson disease.

4 Oct 2009 OBJECTIVE: To assess driving performance in Parkinson disease (PD) under low-contrast visibility conditions. METHODS: Licensed, active drivers with mild to moderate PD (n = 67, aged 66.2 +/- 9.0 years, median Hoehn-Yahr stage = 2) and controls (n = ... Read more...

Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease.

2 Sep 2009 Decision-making and recognition of emotions are often impaired in patients with Parkinson's disease (PD). The orbitofrontal cortex (OFC) and the amygdala are critical structures subserving these functions. This study was designed to test whether ... Read more...

Latest indexed articles for 'Parkinson Disease - Psychology'

These are the very latest articles for this heading:

• Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Nov 2009
• Driving under low-contrast visibility conditions in Parkinson disease. 4 Oct 2009
• Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. 2 Sep 2009
• The influence of facial masking and sex on older adults' impressions of individuals with Parkinson's disease. 30 Aug 2009
• Cognitive characteristics associated with mild cognitive impairment in Parkinson's disease. 16 Aug 2009
• Exercise therapy, quality of life, and activities of daily living in patients with Parkinson disease: a small scale quasi-randomised trial. 9 Aug 2009
• [Comparison of neuropsychological performance according to the age of onset in subjects with Parkinson's disease and Parkinsonism] 30 Jul 2009
• Rivastigmine in Parkinson's disease dementia. 30 Jul 2009
• The spectrum of neuropsychiatric symptoms in patients with early untreated Parkinson's disease. 30 Jul 2009
• Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. 28 Jul 2009
• Automatic activation of motor programs by object affordances in patients with Parkinson's disease. 14 Jul 2009
• The relationship between quality of life and swallowing in Parkinson's disease. 13 Jul 2009
• Determinants of the timing of symptomatic treatment in early Parkinson disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience. 11 Jul 2009
• Application of depression criteria (DSM-IV) in patients with Parkinson's disease. 6 Jul 2009
• The contribution of executive control on verbal-learning impairment in patients with Parkinson's disease with dementia and Alzheimer's disease. 6 Jul 2009
• [Psychometric attributes of the Scales for Outcomes in Parkinson's Disease-Psychosocial (SCOPA-PS): validation in Spain and review] 29 Jun 2009
• Reduced performance in balance, walking and turning tasks is associated with increased neck tone in Parkinson's disease. 28 Jun 2009
• [What roll does the sense of coherence in coping with Morbus Parkinson play?] 26 Jun 2009
• Quality of life in Serbian patients with Parkinson's disease. 25 Jun 2009
• Reduced life-space of non-professional caregivers to Parkinson's disease patients with increased disease duration. 23 Jun 2009

See a longer list of these articles.

Technical information about 'Parkinson Disease'

Definition: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Descriptor UI: D010300

Alternative terms: Parkinson Disease; Idiopathic Parkinson's Disease; Lewy Body Parkinson Disease; Lewy Body Parkinson's Disease; Primary Parkinsonism; Parkinsonism, Primary; Parkinson Disease, Idiopathic; Parkinson's Disease; Parkinson's Disease, Idiopathic; Parkinson's Disease, Lewy Body; Idiopathic Parkinson Disease; Paralysis Agitans;

Related Mesh Headings: Lewy Bodies;

Allowable Qualifiers: blood; cerebrospinal fluid; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C10.228.140.079.862.500; C10.228.662.600.400; C10.574.812;

History Note: 1979(1963)

Technical Notes: drug ther: consider also ANTIPARKINSON AGENTS; /chem ind = PARKINSON DISEASE, SECONDARY/chem ind